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Abstract
Introduction:To understand the potential influence of diversity on themeasurement of
functional impairment in dementia, we aimed to investigate possible bias caused by age,
gender, education, and cultural differences.
Methods: A total of 3571 individuals (67.1 ± 9.5 years old, 44.7% female) from The
Netherlands, Spain, France, United States, UnitedKingdom,Greece, Serbia, and Finland
were included. Functional impairment was measured using the Amsterdam Instrumen-
tal Activities of Daily Living (IADL) Questionnaire. Item bias was assessed using differ-
ential item functioning (DIF) analysis.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any
medium, provided the original work is properly cited, the use is non-commercial and nomodifications or adaptations aremade.
c○ 2020 The Authors. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring published byWiley Periodicals, Inc. on behalf of Alzheimer’s Association
Alzheimer’s Dement. 2020;12:e12021. wileyonlinelibrary.com/journal/dad 1 of 11
https://doi.org/10.1002/dad2.12021
2 of 11 DUBBELMAN ET AL.
Results:Therewere somedifferences in activity endorsement. A few items showed sta-
tistically significantDIF.However, therewas no evidence ofmeaningful itembias: Effect
sizes were low (ΔR2 range 0-0.03). Impact on total scores wasminimal.
Discussion:The results imply a limited bias for age, gender, education, and culture in the
measurement of functional impairment. This study provides an important step in recog-
nizing the potential influence of diversity on primary outcomes in dementia research.
K EYWORD S
Alzheimer’s disease, cross-cultural validation, dementia, differential item functioning, diversity,
functional decline, instrumental activities of daily living, item response theory
1 INTRODUCTION
Impairment in cognitively complex “instrumental activities of daily
living” (IADLs), such as doing grocery shopping, managing personal
finances, and using mobile devices, may be one of the first symptoms
of dementia.1–3 IADL performance is related to quality of life, care-
giver burden, and resource utilization.4 Moreover, IADL impairment in
preclinical stages might be a predictor of progression to dementia.5,6
Therefore, functional impairment is an important and highly relevant
outcome measure for clinical practice and clinical trials. In recently
drafted industry guidelines, the U.S. Food and Drug Administration
(FDA) recommended the use of functional impairment as ameasure for
effectiveness of treatment and of disease progression.7 It is a potential
global outcomemeasure in dementia research.8,9
Because everyday functioning relates to daily life, IADLs may be
especially sensitive to bias caused by various factors, such as age,
gender, and cultural differences. Previous studies have shown gender
effects on traditional IADL instruments,9–12 as they include predom-
inantly household activities, which may be performed more often by
women. Scientific literature concerning cultural and ethnoracial diver-
sity in the context of dementia is scarce.13,14 The selection of activ-
ities to include in an IADL instrument may be culture-specific. For
example, in the United States, it is customary to write checks, whereas
in The Netherlands, people often use online banking. Mere transla-
tion of an instrument does not always account for national (cross-
cultural) disparities,15,16 and although many functional instruments
have been translated into numerous languages, there is no gold stan-
dard for cross-cultural adaptation of questionnaires.17 This empha-
sizes the importance of investigating potential sources of bias and their
influence on item and scale level.
We aimed to study the potential influences of diversity on the
measurement of functional impairment using the Amsterdam IADL
Questionnaire (A-IADL-Q). Specifically, we investigated item bias
caused by various factors: cross-cultural differences (operational-
ized by using country of residence), age, gender, and education.
We obtained data from eight Western countries: The Netherlands,
Spain, France, United States, United Kingdom, Greece, Serbia, and
Finland.
2 METHODS
The present study included data from 3571 individuals with a com-
pleted A-IADL-Q from memory clinics and cognition studies from
eight countries: TheNetherlands (AmsterdamDementia Cohort18 and
European Prevention of Alzheimer’s Dementia Longitudinal Cohort
Study, EPAD19,20), Spain (Compostela Aging Study21,22; EPAD; and
Alfa+ project23), France (investigation of Alzheimer’s predictors in
subjective memory complainers (INSIGHT-preAD) study24; EPAD;
and Socrates study), United States (Butler Alzheimer’s Prevention
Registry25), United Kingdom (EPAD and software architecture for
mental health self management (SAMS) project26), Greece (Greek
Association for Alzheimer’s Disease and Related Disorders), Serbia
(Niš Clinic of Neurology27), and Finland (Helsinki Small Vessel Disease
study).
Participants had some degree of cognitive complaints, or had an
increased genetic or neurovascular risk for cognitive decline. Partici-
pants were recruited from memory clinics, through advertisement, or
from existing databanks. Inclusion criteria ranged from being cogni-
tively normal to having a dementia-related diagnosis. Other relevant
inclusion and exclusion criteria for each cohort in this study can be
found in Table 1. Participants provided written informed consent, and
the studies were approved by their institutional review boards, which
included, in each, consent for data sharing.
2.1 Measures
2.1.1 Amsterdam IADLQuestionnaire (A-IADL-Q)
The Amsterdam IADL Questionnaire (A-IADL-Q) assesses cognitively
complex IADLs that are prone to decline in incipient dementia. It cov-
ers a wide range of activities: The original version contains 70 items,
while the short version (A-IADL-Q-SV) has 30. Both the original and
short versions were used in the included studies. We analyzed both
versions, with a special focus on the short version, because all items
from the short version are also included in the original, and can there-
fore be compared between all participants.
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Unlike many other IADL instruments,28 the A-IADL-Q has been
validated extensively and has been shown to have good internal
consistency, validity, and reliability.29–31 Furthermore, it appears to
be independent of age and gender,30 and sensitive to change over
time.32 The short version was developed to create a more concise
measure, as well as to reduce potential cultural bias by only including
widely relevant activities.33 International use of the A-IADL-Q is
steadily increasing. All translations have gone through a cross-cultural
adaptation process based on procedures described by Beaton et al.34
in which experts and prospective users were asked to evaluate the
translated instrument (a more detailed description of this process can
be found in the SupplementaryMaterial).
The questionnaire is scored using item response theory (IRT), as
described elsewhere.29,31 IRT assumes that an instrument measures a
latent trait, which is represented in a scale ranging from total absence
to abundance of the particular trait.35 The A-IADL-Q latent trait is
“IADL functioning.”30 In IRT, parameters are calculated for each item,
which contain information about item response category location (or
difficulty, ie, at which trait level half the population endorses a given
response category of an item), as well as slope (or discriminatory abil-
ity, ie, howwell an item can distinguish between people with lower and
higher levels of the trait).
All A-IADL-Q itemshave five response categories, ranging fromhav-
ing “no difficulty” in performing an activity to being “unable to perform”
an activity due to cognitive problems. IRT-based T-scores representing
the trait level were calibrated in a memory-clinic population and were
centered around a mean of 50 with a standard deviation (SD) of 10.
Lower scores indicatemore severe functional impairments.
2.1.2 Clinical measures
Mini-Mental State Examination (MMSE, scores range 0–30)36 and
Cambridge Cognition Examination (CAMCOG, scores range 0-107)37
served as general indications of cognitive functioning. For both mea-
sures, lower scores indicate worse cognition. The Clinical Dementia
Rating (CDR)38 was an indicator of functional status. A global CDR
score of 0 represents no dementia, and scores of 0.5 to 3 are related to
more advanced stages of dementia (and thus more functional impair-
ment). Finally, the short form Geriatric Depression Scale (GDS, scores
range 0-15)39 was used to assess depressive symptoms, where higher
scores are indicative of more severe depressive symptoms. Data were
not obtained for all included participants: We excluded individuals liv-
ing in nursing homes (n = 130) because they have limited IADL inde-
pendence.
2.2 Statistical analyses
We investigated item bias using “differential item functioning” (DIF)
analysis. DIF analysis is a technique for identifying items that have dif-
ferent item locations and/or slopes in different groups. DIF is assumed
to occur when the relationship between a test item and the latent trait
HIGHLIGHTS
• Diversity in age, gender, education, and culture may influ-
encemeasurement of instrumental activities of daily living
(IADLs).
• A total of 3571 people from eight countries answered the
Amsterdam IADLQuestionnaire (A-IADL-Q).
• Minor item bias was found for country, with a marginal
influence on total scores.
• No meaningful item bias was found for age, gender, and
education.
• These findings provide evidence for valid measurement of
everyday functioning.
RESEARCH INCONTEXT
• Systematic review: Instrumental activities of daily liv-
ing (IADLs) are important for the diagnosis of dementia
and may form an important outcome measure for clin-
ical trials. IADL measures are widely used internation-
ally. We reviewed almost 200 records from a PubMed
search of cross-cultural comparability of IADLs in demen-
tia and found only a handful of publications targeting
cross-cultural validation, mostly into a single language.
• Interpretations: Our findings of absence of meaningful
bias for cultural differences, age, gender, and education in
the Amsterdam IADL Questionnaire (A-IADL-Q) suggest
that the A-IADL-Q is a suitable instrument for the mea-
surement and international comparison of decline in IADL
functioning in early dementia in a demographically diverse
population.
• Futuredirections: Developmentof new translationsof the
A-IADL-Q can make the instrument truly globally appli-
cable. In addition, ethnoracial disparities should also be
taken into account in future research so that IADLs can be
used as a universal measure.
is not the same across study-irrelevant groups.35 It is considered a
variation in measurement and is therefore undesirable.40 We studied
DIF in the following groups: (1) nationality, using the Dutch cohort
as a reference group, while grouping all other studies by country; (2)
men and women; and, based on median split; (3) young (<67.2 years)
and old age (≥67.2 years); and (4) low (<12 years) and high education
(≥12 years).
For all DIF analyses, aminimum count of one case in at least two dif-
ferent response categories was required in each group for every item.
We used the ordinal logistic regression (OLR) approach, which is often
used and can be performed in standard software. OLR has been shown
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TABLE 2 Demographics and clinical characteristics for all participants, and grouped per country
All
The
Netherlands Spain France
United
States
United
Kingdom Greece Serbia Finland
Total n 3571 1515 1151 509 154 93 61 45 43
Females, n (%)a 1597 (44.7) 637 (42.0) 485 (42.1) 262 (51.5) 104 (67.5) 43 (46.2) 18 (29.5) 25 (55.6) 23 (53.5)
Age (years) 67.14± 9.5 63.78± 8.5 67.84± 10.4 73.48± 6.2 66.65± 4.5 68.42± 5.8 79.99± 6.4 65.44± 13.1 71.69± 2.8
Education years 12.19± 3.9 11.34± 3.2 11.97± 4.4 13.95± 3.7 16.82± 2.3 12.99± 3.1 9.50± 4.3 13.93± 4.3 12.93± 5.5
Dementia
diagnosis, n (%)a
860 (29.9) 647 (47.2) 188 (20.2) 0 (0) 0 (0) 0 (0) 21 (80.8) 4 (8.9) 0 (0)
A-IADL-Q
T-scoreb 58.40± 14.2 51.54± 11.7 61.82± 15.2 67.33± 9.4 67.48± 3.5 71.16± 5.1 39.48± 13.9 61.67± 8.8 66.30± 5.2
Clinical measuresa
MMSE 26.20± 4.6 24.22± 5.0 27.76± 3.7 28.62± 1.2 29.35± 1.0 28.46± 1.5 19.58± 4.6 27.49± 3.6 27.60± 2.2
CAMCOG 78.57± 17.3 78.75± 16.1 80.98± 19.1 — — — 41.62± 9.7 — —
CDR,M (IQR) 0 (0–0.5) 0.5 (0–1) 0 (0–0) 0 (0–0) — 0 (0–0) 2 (0.5–2) — —
GDS 3.66± 3.6 3.80± 3.3 4.09± 4.0 4.33± 4.2 0.85± 1.3 3.52± 4.5 2.38± 3.1 — 2.10± 3.1
All data are displayed asmean± standard deviation, except as stated otherwise. “—” denotes that data were not available.
A-IADL-Q, Amsterdam Instrumental Activities of Daily LivingQuestionnaire; CAMCOG, Cambridge Cognitive Examinations; CDR, Clinical Dementia Rating;
GDS, Geriatric Depression Scale; IQR, interquartile range;M, median;MMSE,Mini-Mental State Examination.
aData were not obtained for all participants.
bThe score shown is based on either the original or short version of the A-IADL-Q, as administered to each participant.
previously to be superior the Mantel-Haenszel procedure.41 We used
the “lordif” package version 0.3-3 for R, developed by Choi et al40;
“lordif” has been used extensively in the literature, ensuring appro-
priateness and replicability of our procedures. In the OLR approach,
a null model and three hierarchically nested models are created and
compared for each item. When DIF is present and constant across all
levels of the latent trait, it is called uniform DIF. The response cate-
gories of an item with uniform DIF are located at a different location
in each group.42 When an item is easier at one level of the trait and
more difficult at another level, it is considered to have non-uniform
DIF.42 Items with non-uniform DIF have different discriminatory abil-
ities in each group. Statistically significant DIF was determined on the
basis of the likelihood-ratio 𝜒2 test with an 𝛼 level of .01, to avoid type
I error, and because multiple nested models are being tested for each
item. Because of inflated type I error in OLR DIF analyses,43 we added
a step to establish presence of practically meaningful DIF,44,45 based
on aMcFadden’s pseudoR2 (ΔR2) value of .035 or larger. This approach
reduces the risk of finding significant but negligible DIF, albeit at the
cost of a reduction in power.43 Furthermore, we used the following
effect size criteria to quantify DIF size: ΔR2 values between .035 and
.070 for moderate, and above .070 for large DIF.43 To refine DIF detec-
tion and effect size estimates, we then performed Monte Carlo simu-
lations over 1000 replications in which the detection criteria as well
as effect size measures are computed repeatedly over simulated data
based on the empirical data sets. The simulated data are generated
under the hypothesis that there is no DIF, while keeping the observed
group differences in trait levels.
As a means of construct validation, Pearson’s r for continuous or
Kendall’s 𝜏 correlation coefficients for ordinal-levelmeasureswere cal-
culated for the association between A-IADL-Q-SV T-scores and age,
education level, genderof theparticipant, cognitive functioning (MMSE
and CAMCOG), functional state (CDR), andmood (GDS).
Data were processed in SPSS Statistics version 2246 and R version
3.6.1.47
3 RESULTS
On average, participants were 67.1 ± 9.5 (m ± SD) years old. Table 2
shows the demographics and clinicalmeasures of all participants, strat-
ified by country.
The overall mean score on the A-IADL-Qwas 58.40± 14.2. A-IADL-
Q scores per country are shown in Table 2.
3.1 Item endorsement
Generally, item endorsement was comparable between countries, as
well as between men and women, younger and older participants, and
participants with lower and higher education. Table 3 highlights a few
activities in which there were apparent differences. “Minor repairs”
was endorsed by a larger percentage of men, as compared to women.
Conversely, “using a washing machine” was endorsed more often by
women. Participants with a lower indication endorsed “withdrawing
cash fromanATM” somewhat less often than participantswith a higher
education. Older participants were less likely to work, compared to
younger participants. Participants fromGreece, Spain, and Serbia used
computers less often than participants from the other countries. Par-
ticipants from the United States appeared to use public transportation
less often than participants from European countries (see Table 3).
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3.2 Item bias
Due to restricted variability in some items, we were unable to ana-
lyze all items. Two hundred seventy-two of 300 items (90.7%) in the
A-IADL-Q-SV were analyzed. Of the items analyzed, 26.6% had statis-
tically significant DIF. Effect sizes were very small for all factors (ΔR2
range .000-.034, see Figure 1). Monte Carlo simulations showed that
the mean p-value for the 𝜒2 statistic across all items varied between
comparisons from .006 to .012, which was close to the .01 𝛼-level used
to detect DIF. Simulation-based thresholds for effect size ranged from
.001 to .018 across all analyses (Figure 1). Lowering of the threshold
would lead to more items being flagged for DIF. The effect sizes, how-
ever, remained very small.
For the original version, 437 of 490 items (89.2%) were analyzed.
Of those, 20.4% had statistically significant DIF. The effects for age,
gender, and education were again small (ΔR2 range .000-.032). Four
items showed meaningful DIF for nationality with a moderate effect.
In Spain, “using the washing machine” (ΔR2 = .043), “making appoint-
ments” (ΔR2 = .064), and “playing card and board games” (ΔR2 = .043)
were flagged. All three items had uniformDIF: The first itemwas more
difficult for Spanish individuals; the other two were easier, as com-
pared to the Dutch reference group. The fourth item had non-uniform
DIF and was found in the French group: “functioning adequately at
work” (ΔR2 = .064). The item appeared to be better at discriminat-
ing between people with lower and higher levels of functional impair-
ment in France than in The Netherlands. We used the DIF results to
re-estimate the T-scores for Spanish and French participants, thereby
correcting for the effect of DIF. In the Spanish group, the mean score
decreased by .16 points on the T-scale, in the French group, the mean
scoredecreasedby .07points. The largest individual differences inboth
countries (−1.14 and−1.33, respectively) corresponded to a difference
of approximately one tenth of an SD, and can therefore be considered
negligible. Figure 2 shows the individual score changes after DIF cor-
rection in Spain and France. There was no meaningful bias for nation-
ality in the other countries. Simulations showed the mean 𝜒2 statis-
tic p-value across all items varied from .008 to .012. The largest ΔR2
effect size was .026 (range .001-.026), which corresponds to a negligi-
ble effect.
3.3 A-IADL-Q-SV construct validation
Overall, all correlations were in the same directions and of sim-
ilar magnitudes as compared to the original validation data from
The Netherlands.30 Age seemed more strongly associated with IADL
impairment in Spain (r = −0.47, 95% confidence interval [CI] = −0.51,
−0.42), Greece (r = −0.31, 95% CI = −0.52, −0.06), and Serbia (r =
−0.48, 95%CI=−0.68,−0.21) than in TheNetherlands (r=−0.08, 95%
CI = −0.13, −0.02). MMSE scores appeared to be less associated with
IADL impairment France (r = 0.11, 95% CI = 0.02, 0.21), United States
(r = 0.12, 95% CI = −0.05, 0.27), and United Kingdom (r = −0.10,
95% CI = −0.33, 0.14), compared to the reference (r = 0.33, 95%
CI = 0.28, 0.38). In these countries, the MMSE had a restricted
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F IGURE 1 DIF effect sizes for country, age, gender, and education in the A-IADL-Q-SV. Green circles represent the empirically foundΔR2
effect sizes; blue asterisks represent the 99th percentileΔR2 effect sizes fromMC simulations. A solid green line is placed at the predetermined
threshold for practically meaningful DIF (ΔR2 = .035); a dashed blue line is placed just above the highest simulated effect size threshold.
Abbreviations: A-IADL-Q, Amsterdam IADLQuestionnaire; DIF, differential item functioning
score range. Conversely, MMSE scores were more strongly associ-
ated with IADL impairment in Serbia (r = 0.56, 95% CI = 0.32, 0.73).
An overview of all correlations can be found in the Supplementary
Material.
4 DISCUSSION
In this study, we demonstrated that the influence of diversity on the
measurement of IADL impairment, as measured with the A-IADL-Q,
seems minimal. Although we found some differences with regard to
activity endorsement between countries, there was no evidence of
practically meaningful item bias caused by various factors, including
age, gender, education, and culture. These findings, together with the
similar associations with demographic, cognitive, and functional mea-
sures as found in earlier validation efforts,30 further support the valid-
ity of the A-IADL-Q.
Addressing potential bias caused by various types of diversity is
highly relevant in dementia research.14 With respect to the measure-
ment of functional impairment, there have been contradictory findings,
with, some studies showing a general comparability of IADLs across
cultures and different ethnoracial groups,8,9 and others reporting
differences between cultures, genders, and ages.48–51 For an opti-
mal comparison of functional outcome in international studies and
clinical trials, a valid, cross-culturally adapted instrument is crucial.
In the present study, the relevance of addressing potential bias was
underscored by the fact that we found some differences in activity
endorsement, particularly in activities related to the household and
to technology. Gender roles can differ between countries, and they
might determine the IADL activities in which one participates. In
Mediterranean countries, it seemed people used computers less often
than in Northern European countries and America.
In our current sample, the effects of DIF were small and thus did
not pass our threshold for practically meaningful DIF. The reason
that we found little evidence of meaningful DIF may be attributed
to the cross-cultural adaptation process that all translations went
through, in which potential cross-cultural differences were identified
beforehand and cultural adaptations were made as necessary. These
changes were minor, and we believe the items included should be
applicable to Western culture in general. As part of the development
of the short version, international experts provided feedback on
the cross-cultural comparability of the items,33 which may explain
the absence of practicallymeaningful itembias for nationality. Because
the A-IADL-Q-SV does not appear to have practically meaningful
item bias, T-scores do not need to be adjusted to be compared across
countries, ages, genders, or levels of education. This suggests that the
A-IADL-Q yields valid and cross-culturally comparable estimations of
functional decline. Previous studies30,31,33 have already shown that
A-IADL-Q scores are independent of age, gender, and education, and
our findings corroborate this. This is an important finding, because
other functional instruments do appear to be biased for gender, age,
and cultural differences.48,49
In the original version, a few items appeared to be biased in Spain
and France. “Making appointments” had the largest DIF effect, and
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F IGURE 2 Scatter plot showing the differences between initial (uncorrected) and DIF-corrected T-scores for the A-IADL-Q in the French (red)
and Spanish (blue) groups, plotted against the uncorrected T-scores. A dashed line is placed at themean change in score in the French and Spanish
groups. Difference in total score ranges from−0.5 to+1.5 on the T-score, corresponding to approximately one tenth of a standard deviation
difference. A solid black line is placed at no change. Abbreviations: A-IADL-Q, Amsterdam IADLQuestionnaire; DIF, differential item functioning
a potential explanation is that examples were added in the Spanish
translation, because language experts indicated that the proposed
translation for the word “appointments” (citas) could be interpreted as
“(romantic) dates,” whereas the intended definitionwas broader. How-
ever, adding examples may actually have restricted the interpretation
of the question to the specific examples given, and led to a loss of the
broader meaning. The other items with DIF had a smaller effect, and
no clear reason for the presence of DIF could be discerned. Despite
the finding of item bias in the original version, the effect on the total
scores wasminimal.
The associations between A-IADL-Q-SV scores and demographic,
cognitive, and functional measures we found here largely correspond
to those previously described for the original version.30 In Spain,
Greece, and Serbia, participants were older than average, and associ-
ations between age and IADL were stronger. In Spain, an association
between age and IADL functioning was found earlier in a group of
patients without dementia.21 In France, the United States, and the
United Kingdom, the studies recruited mainly cognitively healthy
participants, resulting in limited variation in the measure of cognition,
and IADL functioning seemed to be less associated with cognitive
measures.
An important strength of this study is that we used a data-driven
approach to investigate the cross-cultural comparability of IADL. We
usedDIF, which is a powerful procedure to detect variance inmeasure-
ment between groups on an item level, and was possible as a result
of the IRT scoring method. Not only does DIF tell us whether an item
may be biased, but it also provides insight into the impact of the bias
on the overall scores and it allows for correction.We additionally used
simulations to further validate the empirical findings. These advan-
tages allowed us to create a clear picture of possible measurement
variance and impact on the instrument. Another strength of the study
is that we included data from more than 3500 individuals from eight
countries. People with a wide variety of cognitive impairment–related
diagnoses or complaints were included, ranging from subjective cogni-
tive decline to dementia. Furthermore, the age of participants ranged
from adulthood to old age. The large sample size and large variety in
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diagnoses and age contributes to the generalizability of our results and
conclusions.
This study also had a few limitations. First, we included data from
only eight developed, Western countries. Our findings cannot be
generalized to other parts of the world. One study found DIF in an
IADL instrument between different Asian cultures.52 It should also be
noted that we use the term “culture” to refer to each country’s national
culture. Furthermore, we did not have access to information about
ethnicity or race. It is currently unclear what the influence of ethnora-
cial differences are on the measurement of IADLs. Second, our sample
comprised mainly highly educated people. The group we defined as
having low education still received up to 12 years of education. It is
possible that different results would be obtained in samples with less
formal education. Third, the sample size was relatively small in Finland,
Serbia, and Greece. This may have reduced our power to detect DIF.
We tried to address this issue by performing Monte Carlo simula-
tions, which indicated that the predetermined cutoff for practically
meaningful DIF may have been somewhat high. More items would
show DIF, if the threshold was lowered. However, when considering
how these findings influence the total score, the impact seemsminimal
and the DIF effect sizes remain small.
The present study is an important first step in recognizing the influ-
ence of diversity on the measurement of functional impairment, and
future studies should build on these findings. More research is needed
to understand the differences between Western and Oriental and
other cultures, as well as differences between ethnicities and races.
TheA-IADL-Q-SVmight be thepreferred version for future interna-
tional use, as it includes only themost broadly relevant everyday activ-
ities, does not seem to have meaningful item bias, has good construct
validity, and is more pragmatic.
To conclude, we found no indication of the presence of clinically rel-
evant bias caused by several aspects of diversity, including age, gen-
der, education, and cultural differences. This is important, because it
further underscores the potential of the A-IADL-Q, and the short ver-
sion in particular, as an outcomemeasure of daily functioning in clinical
practice and clinical trials.
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